What is VIP studied for?

Published and ongoing research looks at immune regulation and inflammatory signaling; pulmonary and circulatory effects; gut and neurological signaling. These are areas of study, not promised outcomes.

VIP has not been evaluated by the FDA as a finished product. Where a clinician determines it is appropriate, it is dispensed as a compounded preparation pursuant to a patient-specific prescription, filled by a licensed 503A compounding pharmacy. A compounded preparation is not an FDA-approved product.

How is VIP typically used?

Discussed in the literature mostly in inhalational and intravenous research settings. Human evidence is limited and protocol use is individualized. Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.

What are the risks and unknowns with VIP?

Not FDA-approved for any indication. Long-term human safety data does not exist. Effects on blood pressure and heart rate require physician oversight.

Longevity & immune

VIP.

Written by the Elevate Clinical Team

Medically reviewed by Dr. Eric W. Anderson, MD · Last reviewed September 29, 2026

Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026.

Also known as Vasoactive intestinal peptide

A naturally occurring neuropeptide studied for immune regulation, circulation and inflammatory signaling.

Prescription only

Available by prescription following a clinical consultation, dispensed pursuant to a patient-specific prescription and filled by a licensed 503A compounding pharmacy. A compounded preparation is not an FDA-approved product.

Prescription therapies are dispensed by a licensed 503A compounding pharmacy, which fills patient-specific prescriptions only and is not permitted to dispense medications for office use.

This compounded product has not been reviewed, approved, or evaluated by the Food and Drug Administration for safety and effectiveness.

What it is

VIP is a 28-amino-acid neuropeptide found throughout the body, with roles in blood-vessel dilation, gut motility and immune signaling. Research interest centers on its anti-inflammatory and immunomodulatory effects; most of the literature is preclinical or from small clinical studies.

What it's studied for

Immune regulation and inflammatory signaling
Pulmonary and circulatory effects
Gut and neurological signaling

How it's used in practice

Discussed in the literature mostly in inhalational and intravenous research settings
Human evidence is limited and protocol use is individualized

What you should know before asking about it

Not FDA-approved for any indication
Long-term human safety data does not exist
Effects on blood pressure and heart rate require physician oversight

Frequently asked questions.

What is VIP?: VIP is a 28-amino-acid neuropeptide found throughout the body, with roles in blood-vessel dilation, gut motility and immune signaling. Research interest centers on its anti-inflammatory and immunomodulatory effects; most of the literature is preclinical or from small clinical studies.
What is VIP studied for?: Published and ongoing research looks at immune regulation and inflammatory signaling; pulmonary and circulatory effects; gut and neurological signaling. These are areas of study, not promised outcomes.
Is VIP FDA-approved?: VIP has not been evaluated by the FDA as a finished product. Where a clinician determines it is appropriate, it is dispensed as a compounded preparation pursuant to a patient-specific prescription, filled by a licensed 503A compounding pharmacy. A compounded preparation is not an FDA-approved product.
How is VIP typically used?: Discussed in the literature mostly in inhalational and intravenous research settings. Human evidence is limited and protocol use is individualized. Any specific dose, frequency or duration comes from a prescription written for you after labs — never from this page.
What are the risks and unknowns with VIP?: Not FDA-approved for any indication. Long-term human safety data does not exist. Effects on blood pressure and heart rate require physician oversight.

Sources

1.Published literature on VIP Vasoactive intestinal peptide— PubMed, U.S. National Library of Medicine
2.Compounding and the FDA: questions and answers— U.S. Food & Drug Administration
3.Bulk drug substances nominated for use in compounding under section 503A— U.S. Food & Drug Administration
4.Test directory and patient service center locator— Quest Diagnostics

About this page

Written by the Elevate Clinical Team

Medically reviewed by

Dr. Eric W. Anderson, MD

Medical Director

Medically reviewed by Dr. Eric W. Anderson, MD · Last reviewed September 29, 2026. Citations independently verified against PubMed, ClinicalTrials.gov, and FDA sources on August 19, 2026. Educational content only — not medical advice, not a diagnosis, and not an offer to sell any prescription product.

This page is educational reference material. It is not medical advice, not a diagnosis, and not an offer to sell any product. Prescription therapies are dispensed only through licensed, FDA-registered compounding pharmacies after a physician evaluation. Availability, formulations and regulatory status change over time.

Begin your intake Peptide therapy overview